Nanjing Medlander Medical Technology Co.,Ltd. (SHA:688273)
China · Delayed Price · Currency is CNY 31.68
+0.08 (0.25%)
At close: Aug 14, 2026
SHA:688273 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 412.52 | 431.59 | 424.55 | 340.82 | 376.89 | 341.64 |
Revenue Growth | -5.92% | 1.66% | 24.57% | -9.57% | 10.32% | 1.52% |
Gross Profit Gross Profit Growth | 283.23 | 300.64 | 305.49 | 241.9 | 258.01 | 248.98 |
Operating Income Operating Income Growth | 65.3 | 82.39 | 104.94 | 66.12 | 104.57 | 113.6 |
Net Income Net Income Growth | 85.7 | 102.63 | 101.58 | 89.82 | 121.68 | 118.38 |
Earnings Per Share EPS Growth | 0.88 | 1.05 | 1.03 | 0.90 | 1.46 | 1.58 |
EPS Growth | -18.16% | 1.77% | 14.77% | -38.49% | -7.49% | -2.92% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Pelvic Floor Rehabilitation Pelvic Floor Rehabilitation Growth | 160.01 |
Reproductive Rehabilitation Reproductive Rehabilitation Growth | 127.11 |
Sports Rehabilitation Sports Rehabilitation Growth | 8.76 |
Other Products Other Products Growth | 1.64 |
Consumables and Accessories Consumables and Accessories Growth | 122.31 |
Total Total Growth | 419.82 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 788 | 816.45 | 894.98 | 1,097 | 1,216 | 272.62 |
Total Debt Total Debt Growth | 35.6 | 26.42 | 10.6 | 8.51 | 9.43 | 6.22 |
Net Cash (Debt) Net Cash Growth | 752.4 | 790.03 | 884.38 | 1,089 | 1,206 | 266.4 |
Net Cash Growth | -9.53% | -10.67% | -18.77% | -9.75% | 352.86% | 86.98% |
Net Cash Per Share Net Cash Per Share Growth | 7.69 | 8.08 | 8.98 | 10.89 | 14.48 | 3.55 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 92.95 | 105.43 | 122.51 | 136.91 | 126.67 | 148.6 |
Capital Expenditures CapEx Growth | -84.09 | -118.15 | -129.71 | -75.15 | -54.26 | -14.58 |
Free Cash Flow Free Cash Flow Growth | 8.86 | -12.73 | -7.2 | 61.76 | 72.41 | 134.01 |
Free Cash Flow Growth | - | - | - | -14.71% | -45.97% | 27.41% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 68.66% | 69.66% | 71.95% | 70.97% | 68.46% | 72.88% |
Operating Margin | 15.83% | 19.09% | 24.72% | 19.40% | 27.74% | 33.25% |
Pretax Margin | 21.09% | 24.64% | 29.47% | 29.78% | 38.71% | 37.97% |
Profit Margin | 20.77% | 23.78% | 23.93% | 26.35% | 32.29% | 34.65% |
FCF Margin | 2.15% | -2.95% | -1.70% | 18.12% | 19.21% | 39.23% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.800 | 0.800 | 0.800 | 0.600 | 1.300 |
Dividend Per Share Growth | 0% | 0% | 33.33% | -53.85% | - |
Dividend Yield | 2.53% | 1.90% | 3.54% | 1.95% | 4.41% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 36.16 | 40.52 | 22.51 | 37.32 | 26.79 | - |
Forward PE | - | 12.43 | 12.43 | 21.56 | - | - |
P/FCF Ratio | 349.54 | - | - | 54.27 | 45.02 | - |
PS Ratio | 7.51 | 9.64 | 5.39 | 9.83 | 8.65 | - |